Active Extracellular Signal Regulated Kinase 2 (ERK2) Homo sapiens (Human) Active protein

MAPK1; P38; P40; ERK2; ERT1; MAPK2; P42MAPK; P42-MAPK; PRKM1; PRKM2; P41; P41mapk; P41-mapk; Mitogen-Activated Protein Kinase 1; Mitogen-activated protein kinase 2

Add to Cart Distributors
Overview
Properties
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
  • Traits Freeze-dried powder, Purity > 95%
  • Isoelectric Point7.0
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Extracellular Signal Regulated Kinase 2 (ERK2) Packages (Simulation)
  • Active Extracellular Signal Regulated Kinase 2 (ERK2) Packages (Simulation)
  • Active Extracellular Signal Regulated Kinase 2 (ERK2) Figure. Gene Sequencing (Extract)
  • APA930Hu01.png Figure. SDS-PAGE
  • Active Extracellular Signal Regulated Kinase 2 (ERK2) WB Image
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Extracellular Signal Regulated Kinase 2 (ERK2) is a 42-kDa protein serine/threonine kinase that is a member of the MAP kinase family. ERK2 is ubiquitously distributed in tissues with the highest expression in heart, brain, and spinal cord. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. It is reported that ERK2 can interact with STAT3 and treatment of cells with a MEK-ERK inhibitor blocks STAT3 S727 phosphorylation in response to IL-2. Thus a functional ELISA assay was conducted to detect the interaction of recombinant human ERK2 and recombinant human STAT3. Briefly, ERK2 was diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100 μl were then transferred to STAT3-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST and incubated for 1h with anti-ERK2 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody for 1h at 37℃, wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 µL stop solution to the wells and read at 450/630nm immediately. The binding activity of recombinant human ERK2 and recombinant human STAT3 was shown in Figure 1, the EC50 for this effect is 1.06 ug/mL.

Usage

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • Hypericum Perforatum Hydroalcoholic Extract Mitigates Motor Dysfunction and is Neuroprotective in Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s DiseasePubmed:26119304
  • Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndromepubmed:27538909
  • Gonadotropin Stimulation Has Only a Limited Effect on the Concentration of Follicular Fluid Signalling Proteins: An Antibody Array Analysis33575317

Recommend products